Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Market share of the best-selling drugs in Spain 2015, by brand

Market share of the largest-selling pharmaceutical products in pharmacies in Spain in 2015, by brand name

by Statista Research Department, last edited Feb 14, 2016
Market share of the best-selling drugs in Spain 2015, by brand This statistic displays the market share of the largest-selling pharmaceutical products in pharmacies in Spain in 2015, by brand name. During that year, one of the best-selling drug was the antidiabetic Lantus , sold by Sanofi, accounting for 2.2 percent of total generic drug sales.
Show more

Market share of the largest-selling pharmaceutical products in pharmacies in Spain in 2015, by brand name

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Top pharmaceutical drugs"
  • Global overview
  • Select therapy classes - global
  • U.S. overview
  • Select therapy classes - U.S.
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.